Imodium (Loperamide Hydrochloride)

Loperamide hydrochloride acts as a peripheral μ‑opioid receptor agonist in the gut. By binding to these receptors, it decreases smooth‑muscle activity, slows transit time, and allows more water to be reabsorbed from the intestinal lumen, resulting in firmer stools and fewer bowel movements.

The appropriate dose of Imodium is determined by a healthcare professional based on the severity of symptoms, patient age, and clinical condition. Patients should follow the prescriber’s instructions and the product labeling, and should not exceed the recommended amount without medical guidance.

Safety data for loperamide in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their physician before using Imodium, as the prescriber may decide an alternative therapy is more appropriate.

To order Imodium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Imodium’s active ingredient, loperamide, is a peripheral opioid that specifically targets gut motility, offering rapid symptom control with minimal central nervous system effects. Compared with adsorbent agents like bismuth subsalicylate, loperamide provides a more direct reduction in stool frequency, while agents such as diphenoxylate/atropine have a similar opioid mechanism but carry a higher risk of central side effects.

Imodium should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Imodium is taken orally, usually as a tablet. The tablet is swallowed whole with a glass of water. Patients should follow the dosing instructions provided by their healthcare professional and may be advised to take the medication with or without food depending on individual tolerance.

The most serious risks include severe constipation leading to intestinal obstruction, paralytic ileus, and rare cardiac events such as QT‑interval prolongation, especially when combined with strong CYP3A4 inhibitors. If any signs of extreme abdominal pain, vomiting, or irregular heartbeat occur, medical attention should be sought immediately.

Imodium should not be used by individuals with known hypersensitivity to loperamide or any excipients, patients with diarrhea caused by bacterial infection accompanied by fever or blood in the stool, and those with a history of intestinal obstruction, severe hepatic impairment, or certain cardiac conditions without prior medical evaluation.